SpineThera gets a potential suitor: The maker of OxyContin

A non-opioid painkiller being developed by Plymouth-based SpineThera has caught the eye of Purdue Pharma, the maker of OxyContin, which has signed a deal to give the Connecticut pharmaceutical company the exclusive option to acquire SpineThera.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.